Three in 10 females and girls in the United States get pregnant before 20, a rate greater than that in many other wealthy countries significantly. The 14 – to 19-year-old participants in the scholarly study Ms. House joined, half of whom had already had an unintended being pregnant nearly, were offered free birth control and counseled on the benefits of long-acting contraceptives like intrauterine implants and devices, methods used by less than 5 % of teenagers . Related StoriesWeb-based app helps ladies to maintain good health a long time before pregnancyStudy: Visceral fat in early being pregnant can increase risk of gestational diabetesHSS researchers help identify lupus patients at increased risk of problem pregnanciesKaiser Wellness News: Capsules: Long-Performing Contraceptives LESSEN Teen Pregnancy Rates, Research Finds Teenage young ladies who are given usage of long-acting contraceptives such as IUDs or hormonal implants at no cost are less inclined to get pregnant, according to a report in the New England Journal of Medication released Wednesday .The original data show that ponatinib has anti-tumor activity in patients with advanced GIST, in patients with KIT exon 11 mutations particularly, after failing of at least one prior tyrosine kinase inhibitor . The primary endpoint for the trial, clinical benefit price at 16 weeks for patients with Package exon 11 mutations, was 50 %, with a median follow-up of half a year. These data are getting featured today within an oral display at 10:00 a.m. CT at the Annual Getting together with of the American Society of Clinical Oncology being held in Chicago. Related StoriesSausages With Antioxidants From Berries To Prevent CancerFDA grants accelerated approval for Tagrisso to treat sufferers with advanced NSCLCStudy shows rare HER2 missense mutations usually do not spread breasts cancer on the ownThe Stage 2 trial of ponatinib in GIST enrolled 35 patients as of April 7, 2014.